Stay updated on Isatuximab Bendamustine Prednisone in Refractory MM Clinical Trial
Sign up to get notified when there's something new on the Isatuximab Bendamustine Prednisone in Refractory MM Clinical Trial page.

Latest updates to the Isatuximab Bendamustine Prednisone in Refractory MM Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedA new revision entry (Revision: v3.3.3) was added to the history, and an older revision (v3.3.2) along with the HHS Vulnerability Disclosure item were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check19 days agoNo Change Detected
- Check26 days agoNo Change Detected
- Check40 days agoChange DetectedThe Record History shows a new Revision: v3.3.2 entry. The previous Revision: v3.2.0 entry is removed.SummaryDifference0.1%

- Check47 days agoChange DetectedRemoved a government funding/operating status notice banner. The trial record history and study details remain unchanged.SummaryDifference0.7%

- Check61 days agoChange DetectedA new version on 2024-03-17 adds a recruitment status update. The history shows the study was terminated and will not proceed to Phase II, with prior status updates documented.SummaryDifference0.1%

- Check90 days agoChange DetectedThe page now includes an operating-status notice and a version update to v3.2.0, while removing the previous v3.1.0 reference.SummaryDifference12%

- Check97 days agoChange DetectedVersion updated from v3.0.2 to v3.1.0; no substantive content changes detected.SummaryDifference0.3%

Stay in the know with updates to Isatuximab Bendamustine Prednisone in Refractory MM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Isatuximab Bendamustine Prednisone in Refractory MM Clinical Trial page.